Researchers have demonstrated that selective inactivation of the p110&alpha, PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs

Source: PI3K protein: Potential new therapeutic target in pancreatic neuroendocrine tumors


David Cottle

UBB Owner & Administrator